Cargando…

Transient Elastography for the Detection of Liver Damage in Patients with HIV

INTRODUCTION: Highly active antiretroviral therapy (HAART) is effective and well tolerated, but hepatotoxicity is relatively common. Different non-invasive methods are available for detecting liver fibrosis in patients with chronic liver disease. METHODS: Patients who were HIV positive and who had g...

Descripción completa

Detalles Bibliográficos
Autores principales: Sagir, Abdurrahman, Glaubach, Birgit, Sahin, Kurtulus, Graf, Dirk, Erhardt, Andreas, Oette, Mark, Häussinger, Dieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575292/
https://www.ncbi.nlm.nih.gov/pubmed/26143457
http://dx.doi.org/10.1007/s40121-015-0073-y
_version_ 1782390755826860032
author Sagir, Abdurrahman
Glaubach, Birgit
Sahin, Kurtulus
Graf, Dirk
Erhardt, Andreas
Oette, Mark
Häussinger, Dieter
author_facet Sagir, Abdurrahman
Glaubach, Birgit
Sahin, Kurtulus
Graf, Dirk
Erhardt, Andreas
Oette, Mark
Häussinger, Dieter
author_sort Sagir, Abdurrahman
collection PubMed
description INTRODUCTION: Highly active antiretroviral therapy (HAART) is effective and well tolerated, but hepatotoxicity is relatively common. Different non-invasive methods are available for detecting liver fibrosis in patients with chronic liver disease. METHODS: Patients who were HIV positive and who had given their informed consent were included in this cross-sectional study. Transient elastography [FibroScan(®) (FS); Echosens], serum hyaluronic acid (HA), Hepascore (HS), Fibrosis-4 (FIB-4), and aspartate aminotransferase to platelet ratio index (APRI) were used to detect liver fibrosis in the patients. The agreement between FS and the other methods was evaluated. To observe the hepatotoxicity of HAART, patients with chronic viral hepatitis B or C were excluded by detection of hepatitis B surface antigens and hepatitis C virus antibodies. Patients with chronic alcohol intake were excluded by measuring carbohydrate-deficient transferrin (CDT). FS correlation with the duration of therapy with protease inhibitors (PI), nucleoside reverse transcriptase inhibitors (NRTI), and non-nucleoside reverse transcriptase inhibitors (NNRTI) was evaluated. RESULTS: Overall, 203 patients were included in the study. The agreement between the different tests ranged from 64% to 77%: FS vs. HA, 72%; FS vs. APRI, 74%; FS vs. HS, 77%; and FS vs. FIB-4, 64%. After excluding patients with chronic hepatitis B or C and elevated CDT, 153 patients remained for studying the hepatotoxicity of HAART. A significant correlation of FS with the duration of medication intake was observed for PIs (P = 0.026; r = 0.18). NRTI and NNRTI therapy duration did not correlate with FS. CONCLUSIONS: The agreement between FS and other tests ranged from 64% to 77%. A significant correlation was found between liver stiffness and the duration of therapy with PIs, which underlines the known hepatotoxicity of this substance group. FUNDING: Heinz-Ansmann Foundation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40121-015-0073-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4575292
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-45752922015-09-23 Transient Elastography for the Detection of Liver Damage in Patients with HIV Sagir, Abdurrahman Glaubach, Birgit Sahin, Kurtulus Graf, Dirk Erhardt, Andreas Oette, Mark Häussinger, Dieter Infect Dis Ther Original Research INTRODUCTION: Highly active antiretroviral therapy (HAART) is effective and well tolerated, but hepatotoxicity is relatively common. Different non-invasive methods are available for detecting liver fibrosis in patients with chronic liver disease. METHODS: Patients who were HIV positive and who had given their informed consent were included in this cross-sectional study. Transient elastography [FibroScan(®) (FS); Echosens], serum hyaluronic acid (HA), Hepascore (HS), Fibrosis-4 (FIB-4), and aspartate aminotransferase to platelet ratio index (APRI) were used to detect liver fibrosis in the patients. The agreement between FS and the other methods was evaluated. To observe the hepatotoxicity of HAART, patients with chronic viral hepatitis B or C were excluded by detection of hepatitis B surface antigens and hepatitis C virus antibodies. Patients with chronic alcohol intake were excluded by measuring carbohydrate-deficient transferrin (CDT). FS correlation with the duration of therapy with protease inhibitors (PI), nucleoside reverse transcriptase inhibitors (NRTI), and non-nucleoside reverse transcriptase inhibitors (NNRTI) was evaluated. RESULTS: Overall, 203 patients were included in the study. The agreement between the different tests ranged from 64% to 77%: FS vs. HA, 72%; FS vs. APRI, 74%; FS vs. HS, 77%; and FS vs. FIB-4, 64%. After excluding patients with chronic hepatitis B or C and elevated CDT, 153 patients remained for studying the hepatotoxicity of HAART. A significant correlation of FS with the duration of medication intake was observed for PIs (P = 0.026; r = 0.18). NRTI and NNRTI therapy duration did not correlate with FS. CONCLUSIONS: The agreement between FS and other tests ranged from 64% to 77%. A significant correlation was found between liver stiffness and the duration of therapy with PIs, which underlines the known hepatotoxicity of this substance group. FUNDING: Heinz-Ansmann Foundation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40121-015-0073-y) contains supplementary material, which is available to authorized users. Springer Healthcare 2015-07-05 2015-09 /pmc/articles/PMC4575292/ /pubmed/26143457 http://dx.doi.org/10.1007/s40121-015-0073-y Text en © The Author(s) 2015 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Research
Sagir, Abdurrahman
Glaubach, Birgit
Sahin, Kurtulus
Graf, Dirk
Erhardt, Andreas
Oette, Mark
Häussinger, Dieter
Transient Elastography for the Detection of Liver Damage in Patients with HIV
title Transient Elastography for the Detection of Liver Damage in Patients with HIV
title_full Transient Elastography for the Detection of Liver Damage in Patients with HIV
title_fullStr Transient Elastography for the Detection of Liver Damage in Patients with HIV
title_full_unstemmed Transient Elastography for the Detection of Liver Damage in Patients with HIV
title_short Transient Elastography for the Detection of Liver Damage in Patients with HIV
title_sort transient elastography for the detection of liver damage in patients with hiv
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575292/
https://www.ncbi.nlm.nih.gov/pubmed/26143457
http://dx.doi.org/10.1007/s40121-015-0073-y
work_keys_str_mv AT sagirabdurrahman transientelastographyforthedetectionofliverdamageinpatientswithhiv
AT glaubachbirgit transientelastographyforthedetectionofliverdamageinpatientswithhiv
AT sahinkurtulus transientelastographyforthedetectionofliverdamageinpatientswithhiv
AT grafdirk transientelastographyforthedetectionofliverdamageinpatientswithhiv
AT erhardtandreas transientelastographyforthedetectionofliverdamageinpatientswithhiv
AT oettemark transientelastographyforthedetectionofliverdamageinpatientswithhiv
AT haussingerdieter transientelastographyforthedetectionofliverdamageinpatientswithhiv